Medline Inc. (NASDAQ:MDLN) is one of the best NASDAQ stocks to buy according to hedge funds. On February 25, Medline reported its Q4 and full-year 2025 financial results, marking a significant year ...

Medline (Nasdaq:MDLN) today announced an underwritten public offering of 75 million shares of its Class A common stock.

Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of ...

Medline (Nasdaq:MDLN) posted fourth-quarter results that topped sales expectations but fell short of earnings forecasts.

Medline used its first earnings call since going public in December to assure investors that the company is well-positioned to support a health care industry facing what CEO Jim Boyle ...

Medline stressed that it is not selling any shares in this transaction and will not receive any proceeds from the offering. The filing lists Goldman Sachs, Morgan Stanley, BofA Securities, and J.P.

Medline has signed a new supply agreement with Better Life Medical & Surgical Supply, a home medical equipment (HME) provider in Hallandale Beach, Fla.

The CEO of Northfield-based Medline cheered the company’s successful initial public offering late last year following the company’s first earnings call Wednesday.

Medline delivered strong sales despite net income decreases in the fourth quarter and 2025 in its first quarterly filing since becoming a publicly traded company last year.

Medical- and surgical-product company Medline priced a secondary offering of 75 million shares at $41.00 each.

Medline pilots supply chain AI platform Mpower with 10 U.S. health systems to improve real-time data and predictive analytics for providers.

Medline expands recall reprocessed catheters due to particulate risks that may cause infection or embolism, per FDA Class I alert.